Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatocyte nuclear factor 4 gamma (HNF4G) is a member of the nuclear receptor superfamily, functioning as a transcription factor. Encoded by the HNF4G gene, it is structurally similar to HNF4 alpha but has distinct tissue distribution—expressed in pancreas, kidney, small intestine, and testis, but largely absent in liver. HNF4G regulates gene expression involved in cell differentiation, especially in the intestinal epithelium and enterocyte lineage, and plays roles in metabolic and developmental pathways. Loss of HNF4G impairs enterocyte differentiation. It is implicated in cancer development, notably associated with poor prognosis due to its inhibition of caspase-dependent apoptosis, and is also linked to diabetes and metabolic diseases[1][2][3][4][5]. The protein is considered an orphan nuclear receptor, with some evidence for fatty acids as potential non-exchangeable endogenous co-factors rather than traditional ligand-binding[2].
Modulation of gene transcription by binding to specific DNA cis-regulatory regions as a nuclear receptor/transcription factor[1][2][3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatocyte nuclear factor 4 gamma (HNF4G).